Observed in Jim Carroll’s archive on September 16, 2026.
At Genentech, a member of the Roche Group, I addressed 550 executives in San Francisco and challenged them to think beyond breakthrough science toward the broader reinvention made possible by exponential genomics.
Source: Keynote Case Study: Genentech: Personalized Medicine Is Moving From Possibility To Platform..